Top News :  

2012 Economic Outlook - Report Highlights Valeant Pharmaceuticals Int (USA) and The Dow Chemical Company

Thursday, February 02, 2012 9:01 AM

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=847441&ProfileId=051205&sourceType=1

HONG KONG -- (Marketwire) -- 02/02/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Valeant Pharmaceuticals Int (USA) (NYSE: VRX) and The Dow Chemical Company (NYSE: DOW). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=VRX&cob=DOW.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Valeant Pharmaceuticals Int (USA) for its current position within the healthcare industry. Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. The full research report on Valeant Pharmaceuticals Int (USA) (NYSE: VRX) is available here: www.BrightonMarkets.com/index.php?coa=VRX.

Brighton Markets has released research on The Dow Chemical Company for its changing role within the basic materials industry. The Dow Chemical Company (Dow) is a diversified manufacturer and supplier of products used primarily as raw materials in the manufacture of customer products and services worldwide. It operates in eight segments. The full research report on The Dow Chemical Company (NYSE: DOW) is available here: www.BrightonMarkets.com/index.php?cob=DOW.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact:

Jean Barnes
Email Contact
www.BrightonMarkets.com

(Source: Market Wire )
(Source: Quotemedia)

Follow iStockAnalyst on Twitter Follow iStockAnalyst on Twitter
Subscribe to Email Alerts

Comments Closed





Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.